首页> 美国卫生研究院文献>The Journal of Neuroscience >Investigation of the failure of parenterally administered haloperidol to antagonize dopamine released from micropipettes in the caudate
【2h】

Investigation of the failure of parenterally administered haloperidol to antagonize dopamine released from micropipettes in the caudate

机译:胃肠外给药氟哌啶醇不能拮抗从尾部微量移液管释放的多巴胺的研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An anomaly in the experimental data underlying the theory that neuroleptics act by blockade of dopaminergic neurotransmission is the repeatedly demonstrated failure in several laboratories of parenterally administered neuroleptics to antagonize electrophysiologic actions of locally applied dopamine (DA) in striatum. This failure is enigmatic since many investigators have successfully demonstrated antagonism when both dopamine and neuroleptic are applied directly to striatal neurons by microiontophoresis. We used multibarrel micropipettes to pressure- eject DA agonists onto rat caudate neurons while observing the ability of parenterally administered haloperidol to block the inhibitory actions of dopaminergic agonists on neuronal activity. Experiments performed at times of maximal behavioural effect of haloperidol did not demonstrate agonist-antagonist interaction. This result has been obtained by four other teams of investigators. A variety of pharmacologic manipulations were employed to help solve this enigma. Acute treatment with reserpine and alpha-methyl-paratyrosine, performed to minimize any possible interference by endogenous DA, did not permit blockade of dopamine by haloperidol. To see if this failure of antagonism could be generalized to other DA agonists, apomorphine, amphetamine, and phencyclidine (PCP) were also investigated. Although the direct dopaminergic agonist apomorphine was not antagonized by haloperidol, the indirect DA agonist PCP was successfully antagonized. Amphetamine, which has both direct and indirect actions when applied locally, was not antagonized. Antagonism of direct agonists was demonstrated in rats with unilateral 6-hydroxydopamine-induced lesions of the nigrostriatal pathway. In these preparations, parenterally administered haloperidol reversed the receptor-mediated supersensitivity to the inhibitory effects of locally applied DA and apomorphine.(ABSTRACT TRUNCATED AT 250 WORDS)
机译:在抗精神病药物通过阻断多巴胺能神经传递而起作用的理论基础上的实验数据中的一个异常现象是,在多次胃肠外给药的抗精神病药物的实验室中,反复证明失败了,它们无法拮抗纹状体中局部应用的多巴胺(DA)的电生理作用。由于许多研究者已经成功地证明了拮抗作用,因此当多巴胺和抗精神病药通过微离子电渗疗法直接应用于纹状体神经元时,这种失败是难以置信的。我们使用多管微量移液器将DA激动剂压射到大鼠尾状神经元上,同时观察胃肠外给药氟哌啶醇阻断多巴胺能激动剂对神经元活性的抑制作用的能力。在氟哌啶醇的最大行为作用时间进行的实验未证明激动剂-拮抗剂相互作用。其他四个研究人员小组已获得此结果。人们采用了各种药理学方法来帮助解决这一难题。用利血平和α-甲基-对酪氨酸进行的急性治疗(尽量减少内源性DA的可能干扰)不允许氟哌啶醇对多巴胺的阻断。为了了解这种拮抗作用是否可以推广到其他DA激动剂,还研究了阿扑吗啡,苯丙胺和苯环利定(PCP)。尽管氟哌啶醇不能拮抗直接的多巴胺能激动剂阿扑吗啡,但成功地拮抗了间接DA激动剂PCP。苯丙胺在局部使用时具有直接和间接作用,但没有拮抗作用。在具有单侧6-羟基多巴胺诱导的黑质纹状体途径损害的大鼠中证明了直接激动剂的拮抗作用。在这些制剂中,胃肠外给药氟哌啶醇使受体介导的超敏性逆转了对局部应用DA和阿扑吗啡的抑制作用。(摘要截短为250字)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号